Supiana Dian Nurtjahyani, Rasyadan Taufiq Probojati, Arif Nur Muhammad Ansori, Mochammad Amin, Retno Handajani
Supiana Dian Nurtjahyani1*, Rasyadan Taufiq Probojati2,3, Arif Nur Muhammad Ansori4, Mochammad Amin5, Retno Handajani6
1Faculty of Teaching and Education, Ronggolawe University, Tuban, 62381, East Java, Indonesia.
2Division of Molecular Biology and Genetics, Generasi Biologi Indonesia Foundation, Gresik, 61171, East Java, Indonesia.
3Faculty of Agriculture, Universitas Kadiri, Kediri, 64115, East Java, Indonesia.
4Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia.
5Institute of Tropical Disease, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia.
6Faculty of Medicine, Universitas Airlangga, Surabaya, 60115, East Java, Indonesia.
Volume - 14,
Issue - 8,
Year - 2021
This study aimed to analyzed the haplotype network and constructed the phylogenetic tree topology of hepatitis C virus (HCV) in Tuban, Indonesia and those from other countries, to determine the visualize genealogical relationship and inference about gene connected. The HCV isolates were collected from blood transfusion center of Tuban, East Java, Indonesia in 2015 and as a comparison, also the sequences of HCV isolates were retrieved from the GenBank®, National Center of Biotechnology Information (NCBI), USA database. To constructed of distribution map was performed through median joining analysis using Haplotype Network v4.6, whereas to constructed and phylogenetic model analyses were constructed based on the NS5B and 5’UTR regions using MEGA X, maximum-likelihood method based on the Tamura-Nei model. In the HCV NS5B region haplotype network showed high haplotype diversity (Hd=1.00) in 22 haplotypes. Based on phylogenetic analysis 3 sample isolates Tuban (BDT-55-p23, BDT-79-p23 and BDT-112-p23) were identified one group and closely related to isolates from Indonesia. However, isolates Tuban also have the same sequence characters as the isolates from Thailand. It was also confirmed in haplotype network that the three isolates are connected to each other. The identification of HCV genotypes circulating in blood donors in the Tuban of East Java confirmed were closely related to HCV isolates from Indonesia and Thailand. Therefore, this result might contribute in a better medical management towards HCV.
Cite this article:
Supiana Dian Nurtjahyani, Rasyadan Taufiq Probojati, Arif Nur Muhammad Ansori, Mochammad Amin, Retno Handajani. Haplotype Network Analysis and Phylogenetic Tree Construction of Hepatitis C Virus (HCV) Isolated from Tuban, Indonesia. Research Journal of Pharmacy and Technology. 2021; 14(8):4231-5. doi: 10.52711/0974-360X.2021.00734
Supiana Dian Nurtjahyani, Rasyadan Taufiq Probojati, Arif Nur Muhammad Ansori, Mochammad Amin, Retno Handajani. Haplotype Network Analysis and Phylogenetic Tree Construction of Hepatitis C Virus (HCV) Isolated from Tuban, Indonesia. Research Journal of Pharmacy and Technology. 2021; 14(8):4231-5. doi: 10.52711/0974-360X.2021.00734 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-8-40
1. Nurtjahyani SD, Amin M, Handajani R. Identification of hepatitis C virus genotypes in volunteer blood donors from blood transfusion center of Tuban, Indonesia. Malay J Microbiol. 2020; 16(1): 29-33.
2. Utama A, Tania NP, Dhenni R, et al. Genotype diversity of hepatitis C virus (HCV) in HCV-associated liver disease patients in Indonesia. Liver Int. 2010; 30(8): 1152-1160.
3. Pfaender S, Brown RJP, Pietschmann T, et al. Natural reservoirs for homologs of hepatitis C virus. Emerg Microbes Infect. 2014; 3: e21.
4. Simmonds P, Bukh J, Combet C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005; 42: 962–73.
5. Murphy DG, Willems B, Deschenes M, et al. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 59 untranslated region sequences. J Clin Microbiol. 2007; 45:1102–1112.
6. Friedman LS. Liver, Biliary Tract, & Pancreas Disorders. In: Eds. Papadakis MA, McPhee SJA, Rabow MW. Current Medical Diagnosis & Treatment. Fifty- Second Edition. New York. 662-682; 2013.
7. El-Shamy A, Hotta H. Impact of hepatitis C virus heterogeneity on interferon sensitivity: An overview. World J Gastroenter. 2014; 20:7555- 7569.
8. Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource. Hepatology. 2014; 59: 318-327.
9. Lavanchy D. Evolving Epidemiology of Hepatitis C Virus. Clin Mcrobiol Infect. 2011; 17: 107.
10. The´ze´ J, Lowes S, Parker J, et al. Evolutionary and Phylogenetic Analysis of the Hepaciviruses and Pegiviruses. Genome Biol. Evol. 2015; 7(11): 2996–3008.
11. Holland-Staley CA, Kovari lC, Golenberg EM, et al. Genetic diversity and response to IFN of the NS3 protease gene from clinical strains of the hepatitis C virus. Archives of Virology. 2002; 147: 1385-1406.
12. Jeffers LJ, Cassidy W, Howell CD, et al. Peginterferon alfa2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1. Hepatology. 2004; 39: 1702–8.
13. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet. 2001; 358: 958–65.
14. Galli A, Bukh J. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus. Trends Microbiol. . 2014; 22:354–364.
15. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatology. 2014; 61: 45-57.
16. Bennett H, Waser N, Johnston K, et al. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatology Inter. 2015; 9(3): 378-390.
17. Nurtjahyani SD, Amin M, Handajani R. Detection of hepatitis C virus RNA in blood donors with nested PCR technique. Biomed Engin. 2016; 2(2): 1-5.
18. Inoue Y, Sulaiman HA, Matsubayashi K, et al. Genotypic analysis of hepatitis C virus in blood donors in Indonesia. Am J Trop Med Hyg. 2000; 62: 92–8.
19. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol. 2007; 5: 453–463.
20. Mardulyn P. Trees and/or networks to display intraspecific DNA sequence variation?. Mol. Biol. 2012; 21: 3385-3390.
21. Paradis E. Analysis of haplotype networks: The randomized minimum spanning tree method. Methods Ecol Evol. 2018; 9:1308–1317.
22. Apichartpiyakul C, Chittivudikarn C, Miyajima H, et al. Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. J Clinical Microbiol. 1994; 32: 2276-2279.
23. Doi H, Apichartpiyakul C, Ohba KI, et al. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and indentification of novel subtyphees of HCV major type 6. J Clinical Microbiol. 1996; 34(3): 569-574.
24. Leigh JW, David B. POPART: full-feature software for haplotype network construction. Methods Ecol Evol. 2015; 6: 1110–1116.
25. Trickey A, Hiebert L, Perfect C, et al. Hepatitis C virus elimination in Indonesia: Epidemiological, cost and cost-effectiveness modelling to advance advocacy and strategic planning. Liver Int. 2020;40(2):286-297.
26. Sibley A, Han KH, Abourached A, et al. The present and future disease burden of hepatitis C virus infections with today's treatment paradigm ‐ volume 3. J Viral Hepatitis. 2015; 22: 21‐41.
27. Heffernan A, Cooke GS, Nayagam S, Thursz M, Hallett TB. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model. Lancet. 2019; 393(10178): 1319‐1329.
28. Humairah I, Lukitasari L, Handajani R, et al. Prevalence and genotype distribution of hepatitis C virus among intravenous drug users (IDUs) in Surabaya, Indonesia. Research Journal of Pharmacy and Technology. 2021; 14(4).
29. Amin M, Juniastuti J, Utsumi T, et al. The prevalence and subtype distribution of hepatitis c virus infection among hemodialysis patients in a private hospital in Surabaya, Indonesia. Microbiol Indones. 2013; 6(4): 173-179.